Cellectis ADR (NASDAQ: CLLS) is -17.78% lower on its value in year-to-date trading and has touched a low of $1.41 and a high of $3.38 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CLLS stock was last observed hovering at around $1.51 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $1.48, the stock is -12.98% and -18.95% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.21 million and changing -1.99% at the moment leaves the stock -32.41% off its SMA200. CLLS registered -43.51% loss for a year compared to 6-month loss of -31.48%. The firm has a 50-day simple moving average (SMA 50) of $1.82594 and a 200-day simple moving average (SMA200) of $2.189745.
The stock witnessed a -14.45% gain in the last 1 month and extending the period to 3 months gives it a -22.11%, and is -20.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.52% over the week and 9.09% over the month.
Cellectis ADR (CLLS) has around 221 employees, a market worth around $106.69M and $29.07M in sales. Profit margin for the company is -294.25%. Distance from 52-week low is 4.96% and -56.21% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.57%).
with sales reaching $20.42M over the same period.The EPS is expected to grow by 69.99% this year, but quarterly earnings will post 506.92% year-over-year. Quarterly sales are estimated to grow 999.20% in year-over-year returns.
Cellectis ADR (CLLS) Top Institutional Holders
The shares outstanding are 100.09M, and float is at 69.26M with Short Float at 0.29%.
The top institutional shareholder in the company is LONG FOCUS CAPITAL MANAGEMENT, LLC with over 4.62 million shares valued at $8.63 million. The investor’s holdings represent 6.4299% of the CLLS Shares outstanding. As of 2024-06-30, the second largest holder is CAPITAL INTERNATIONAL INVESTORS with 1.85 million shares valued at $3.46 million to account for 2.5746 of the shares outstanding. The other top investors are UBS ASSET MANAGEMENT AMERICAS INC which holds 1.44 million shares representing 2.0029% and valued at over $2.69 million, while BAILLIE GIFFORD & CO holds 0.9854 of the shares totaling 0.71 million with a market value of $1.32 million.
Cellectis ADR (CLLS) Insider Activity
#####
